semaglutide and alcoholism A new pill form of GLP-1 is making the weight loss drug more accessible GLP-1 Semaglutide Promising for Alcohol

A recent study suggests that patients taking Ozempic and Wegovy may face an elevated risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing sudden vision loss

Quantifiable improvement data (keloid reduced from 15mm to 8mm diameter after two treatments) supports continued treatment medical necessity and helps justify additional sessions if the patient needs more than the initial seven-lesion limit suggests

GLP1-RA, glucagon-like peptide-1 receptor agonist

The biologic triggers for any particular individuals autoimmune disease are complex and personal, and taking an obesity first approach without also addressing the underlying autoimmune disease may expose patients to unnecessary risk from poorly controlled inflammation, she said